The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bychkova N.Yu.

State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Lemytskaya V.E.

CIDK Ostozhenka

Sokolovskaya Yu.A.

LLC Baiersdorf

Lipova E.V.

State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Glazko I.I.

State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Iatrogenic Hypermelanoses in a Doctor’s Practice

Authors:

Bychkova N.Yu., Lemytskaya V.E., Sokolovskaya Yu.A., Lipova E.V., Glazko I.I.

More about the authors

Read: 2098 times


To cite this article:

Bychkova NYu, Lemytskaya VE, Sokolovskaya YuA, Lipova EV, Glazko II. Iatrogenic Hypermelanoses in a Doctor’s Practice. Russian Journal of Clinical Dermatology and Venereology. 2024;23(6):730‑739. (In Russ.)
https://doi.org/10.17116/klinderma202423061730

Recommended articles:
Hardware technologies in rosa­cea treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):814-821
Pathogenetically justified treatment of hype­rtrophic scars: a review of modern methods. Russian Journal of Clinical Dermatology and Vene­reology. 2026;(3):334-340
Therapeutic physical factors in comprehensive reha­bilitation for patients with poly­pous rhinosinusitis (Handbook, 2025). Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(4):67-90
Pathomorphosis of transplanted C6 glioma treated with a 1267 nm wave­length laser. Russian Journal of Archive of Pathology. 2026;(2):52-58
Latent Eustachian tube dysfunction in young athletes (swimmers, hockey players) with rhinosinusitis. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2026;(2):23-33

References:

  1. Peer RF, Shabir N. Iatrogenesis: A review on nature, extent, and distribution of healthcare hazards. J Family Med Prim Carё. 2018;7(2):309-314.  https://doi.org/10.4103/jfmpc.jfmpc_329_17
  2. Cestari TF, Dantas LP, Boza JC. Acquired hyperpigmentations. An Bras Dermatol. 2014;89(1):11-25.  https://doi.org/10.1590/abd1806-4841.20142353
  3. Maghfour J, Olayinka J, Hamzavi IH, Mohammad TF. A Focused review on the pathophysiology of post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2022;35(3):320-327.  https://doi.org/10.1111/pcmr.13038
  4. Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R. Skin Pigmentation Types, Causes and Treatment-A Review. Molecules. 2023; 28(12):4839. Published 2023 Jun 18.  https://doi.org/10.3390/molecules28124839
  5. Kubanova AA, Manturova NE, Gallyamova YuA. Guide to cosmetology. M.: Scientific Review; 2020. (In Russ.).
  6. Burylina OM, Karpova AV. Cosmetology: clinical manual. M.: GEOTAR-Media; 2018. (In Russ.).
  7. Nipshagen MD, Velthuis PJ, Mosmuller DGM. Periorbital postinflammatory hyperpigmentation after plasma exeresis. Dermatol Ther. 2020;33(3):e13404. https://doi.org/10.1111/dth.13404
  8. Park JY, Park JH, Kim SJ, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44(2):118-124.  https://doi.org/10.1111/cup.12849
  9. Obshcherossijskaya obshchestvennaya organizatsiya «Rossijskoe obshchestvo dermatovenerologov i kosmetologov». Proekt klinicheskikh rekomendatsij «Postvospalitel’naya giperpigmentatsiya», 2022. (In Russ.). Accessed September 02, 2024. https://www.rodv.ru/klinicheskie-rekomendacii
  10. Bychkova NYu, Lemytskaya VE, Sokolovskaya YuA, Zhukova OV, Kasikhina EI. Review of modern melasma treatment methods. Meditsinskiy sovet = Medical Council. 2024;(14):108-116.  https://doi.org/10.21518/ms2024-349
  11. Bhattar PA, Zawar VP, Godse KV, Patil SP, Nadkarni NJ, Gautam MM. Exogenous Ochronosis. Indian J Dermatol. 2015;60(6):537-543.  https://doi.org/10.4103/0019-5154.169122
  12. Philipp-Dormston WG, Vila Echagüe A, Pérez Damonte SH, et al. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study. Int J Cosmet Sci. 2020; 42(4):377-387.  https://doi.org/10.1111/ics.12626
  13. Vachiramon V, Sakpuwadol N, Yongpisarn T, Anuntrangsee T, Palakornkitti P. Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: A randomized, controlled trial. J Cosmet Dermatol. 2024;23(7):2450-2457. https://doi.org/10.1111/jocd.16287
  14. Vachiramon V, Leerunyakul K, Kositkuljorn C, Chayavichitsilp P. Combined isobutylamido thiazolyl resorcinol and low-fluence Q-switched Nd: YAG laser for the treatment of facial hyperpigmentation: A randomized, split-face study. J Cosmet Dermatol. 2021;20(6):1724-1731. https://doi.org/10.1111/jocd.13790
  15. Rubin AT, Tsaknakis Z, Sammain A. Treating Post-inflammatory hyperpigmentation with a tyrosinase-inhibitor. Prime Journal. 2022;12(1):28-32. Accessed September 02, 2024. https://www.prime-journal.com/treating-post-inflammatory-hyperpigmentation-with-a-tyrosinase-inhibitor
  16. Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta Derm Venereol. 2015;95(2):201-205.  https://doi.org/10.2340/00015555-1899

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.